about
Genetically-encoded tools for cAMP probing and modulation in living systemsReconstruction of mouse testicular cellular microenvironments in long-term seminiferous tubule cultureRescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation.Selective regulation of Notch ligands during angiogenesis is mediated by vimentinCANDLES, an assay for monitoring GPCR induced cAMP generation in cell cultures.A novel targeted therapy of Leydig and granulosa cell tumors through the luteinizing hormone receptor using a hecate-chorionic gonadotropin beta conjugate in transgenic mice.Adrenocortical tumorigenesis, luteinizing hormone receptor and transcription factors GATA-4 and GATA-6.Use of hecate-chorionic gonadotropin beta conjugate in therapy of lutenizing hormone receptor expressing gonadal somatic cell tumors.MicroRNAs-role in lung cancer.How to Train a Cell-Cutting-Edge Molecular Tools.Adrenocortical tumorigenesis in transgenic mice expressing the inhibin alpha-subunit promoter/simian virus 40 T-antigen transgene: relationship between ectopic expression of luteinizing hormone receptor and transcription factor GATA-4.Keratin 8-deletion induced colitis predisposes to murine colorectal cancer enforced by the inflammasome and IL-22 pathway.Functional consequences of knocking down porcine prostaglandin synthases in SK-6 swine kidney cell line.A novel treatment strategy for ovarian cancer based on immunization against zona pellucida protein (ZP) 3.Inhibition of Akt signaling by the lignan matairesinol sensitizes prostate cancer cells to TRAIL-induced apoptosis.Heat stress downregulates FLIP and sensitizes cells to Fas receptor-mediated apoptosis.REPLACR-mutagenesis, a one-step method for site-directed mutagenesis by recombineering.Comprehensive review on betulin as a potent anticancer agent.Luteinizing Hormone and GATA4 Action in the Adrenocortical Tumorigenesis of Gonadectomized Female Mice.Assisted large fragment insertion by Red/ET-recombination (ALFIRE)--an alternative and enhanced method for large fragment recombineering.Retinoblastoma protein (RB) interacts with E2F3 to control terminal differentiation of Sertoli cells.Diatom-inspired skeletonisation of insulin - Mechanistic insights into crystallisation and extracellular bioactivity.Carapace surface architecture facilitates camouflage of the decorator crab Tiarinia cornigera.Targeted therapy for adrenocortical tumors in transgenic mice through their LH receptor by Hecate-human chorionic gonadotropin beta conjugate.The snapping shrimp dactyl plunger: a thermomechanical damage-tolerant sandwich composite.Molecular cloning and spatiotemporal expression of prostaglandin F synthase and microsomal prostaglandin E synthase-1 in porcine endometrium.Steroid receptor coactivator-3 is required for progesterone receptor trans-activation of target genes in response to gonadotropin-releasing hormone treatment of pituitary cells.Optogenetics in cancer drug discovery.A vital region for human glycoprotein hormone trafficking revealed by an LHB mutation.A novel inactivating mutation of the LH/chorionic gonadotrophin receptor with impaired membrane trafficking leading to Leydig cell hypoplasia type 1.G protein-coupled receptor transactivation: from molecules to mice.Mixed chelate copper complex, Casiopeina IIgly®, binds and degrades nucleic acids: A mechanism of cytotoxicityTargeting Somatostatin Receptors By Functionalized Mesoporous Silica Nanoparticles - Are We Striking Home?FSHR Trans-Activation and OligomerizationHistone Deacetylase Inhibitors and Phenotypical Transformation of Cancer CellsInduction of apoptosis by a novel copper-based anticancer compound, casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cellsHematotoxicity response in rats by the novel copper-based anticancer agent: casiopeina IIPreparing biomedical students for the unknown: Some unusual challenges for students to help them understand the fundamentals of empirical researchHistone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory propertiesThe Pathogenic TSH β-subunit Variant C105Vfs114X Causes a Modified Signaling Profile at TSHR
P50
Q26781567-29E507CE-D43D-4C21-B9C1-8831D33E3514Q27319183-1B1736B5-9906-446F-A68D-E71A0060D200Q33719668-9C7E083F-504B-41A8-AFFD-6E9C03FF119CQ33790752-F425CD0A-84FC-4853-A70E-867BA9D031CDQ34491401-63102347-A8F1-4A6E-BC35-800DD8C08A7FQ34768470-C78AD0B4-A7FC-4039-BF11-5B27385E7E51Q36751326-7E3E06C5-2F5A-4966-9737-8BEAA76EE64EQ36760800-D51FDC21-2B83-48B5-81CD-85A31902AC11Q37679619-2F9E9229-7F68-4D80-94F2-D6D12E439F9DQ37692030-933867B4-D9A9-4B54-AF31-9C34BE559CD2Q38338837-FB185B96-D7EC-4EA7-A80E-2061FDEE796EQ38768002-B656EB9F-2632-4592-A030-FCEE7C74B936Q38905129-5CB4E046-796F-40E9-BBB6-14BBCD168C22Q39462922-DF61DAAF-85D5-4119-B7DE-51932DFB5F60Q39771163-C219FF4B-78BC-4048-B2C0-2FBB5E485D32Q40549981-5E5AE987-4CC5-4D3A-BFC0-381E34E3CBA3Q40988187-59B6C32B-BC56-4DC5-A6F0-54BE198730F5Q41839933-5C0464C3-F306-4C22-866C-BDCC54A1A32FQ41924524-86E70E2F-0EB5-4555-BED1-72533B652101Q41956199-71895415-F376-4A0D-ABC1-D152A4292CEAQ42606304-9ABB1925-5783-4444-B3D4-0BDE82441ED5Q46280785-1A254C28-A79E-4739-A462-6078B3A53068Q46547654-22279763-9E0F-4A13-AD62-F806E7332382Q46570538-CB91DB2E-51A9-4A4F-B38C-30EBEFB0441EQ47329947-1ECAEA94-9DBE-4174-9915-85BFDABE2A06Q48117068-06C415ED-CCCF-487B-9D51-E168BC017D85Q48521586-0A0AFC45-B390-41E4-872F-17DBFF6DFCDFQ49982038-18F0A388-BF7E-4831-A1EC-4E7ACC61C084Q50487206-B76A7EC9-C6B4-415C-9C33-19969E2C7AD5Q50595345-16488A9D-0C14-4643-B779-E01FA64D901BQ50714391-8B4A3BED-2B7C-40FE-ABC2-EF8B26FE663EQ58417441-DC4F0A3E-C549-426D-9529-E6FA5851E693Q60590330-360E2148-11F8-4023-9063-F6E00CEC9629Q60956605-A592B163-3D9F-41D4-BB39-54B96ADC9D5FQ64243953-89311660-6586-438C-8384-83CBB9433DC6Q73502954-C7A6855B-3171-4FD1-8D0B-5B5CBBBC0DA4Q79322625-4009E40A-8FA8-4695-BB9D-5987F9109DE7Q90118455-0BD0667D-07D5-4085-8D16-76C1EEE01DBCQ90398667-7D3925A0-3542-4200-810C-831BBD2D2985Q91191093-DF7F73D6-53C8-4873-A307-62984B7EFF60
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Adolfo Rivero-Müller
@ast
Adolfo Rivero-Müller
@en
Adolfo Rivero-Müller
@es
type
label
Adolfo Rivero-Müller
@ast
Adolfo Rivero-Müller
@en
Adolfo Rivero-Müller
@es
prefLabel
Adolfo Rivero-Müller
@ast
Adolfo Rivero-Müller
@en
Adolfo Rivero-Müller
@es
P1053
A-5120-2008
P106
P21
P2798
P31
P3829
P3835
adolfo-rivero-muller
P496
0000-0002-9794-802X